返回 Agenda
Session Chair(s)
Janet Lv, MS, RPH
Senior Consultant, Roche Pharma Product Development China
Roche , China
Speaker(s)
Adaptive Licensing
Lisa Tan, PHD
Health Sciences Authority, Singapore, Singapore
Deputy Director
US Breakthrough and Oncology New Regulations/Policies
Michelle Rohrer, PHD
Genentech, A Member of the Roche Group, United States
Senior Vice President, Global Head of Product Development Regulatory and Policy
EU New Initiatives
Anette Hjelmsmark, MS
Novo Nordisk A/S, Denmark
Senior Director Regulatory Policy